Insider Trading March 16, 2026

General American Investors VP Adds $74,850 in Preferred Shares

Eugene S Stark increases his stake in GAM's 5.95% preferred stock; company highlights a long dividend history and a double-digit yield

By Leila Farooq GAM
General American Investors VP Adds $74,850 in Preferred Shares
GAM

Eugene S Stark, Vice President Administration/CCO/PFO at General American Investors Co Inc (NYSE: GAM), bought 3,000 shares of the company's 5.95% Preferred Stock at $24.95 per share, a transaction valued at $74,850. After the purchase, Stark directly holds 27,000 shares of that preferred issue. The company is noted for 54 consecutive years of dividend payments and currently shows a 10.86% dividend yield, according to InvestingPro data.

Key Points

  • Eugene S Stark acquired 3,000 shares of General American Investors’ 5.95% Preferred Stock at $24.95 per share, totaling $74,850.
  • Following the purchase, Stark directly owns 27,000 shares of the 5.95% Preferred Stock.
  • InvestingPro data cited in the report states that General American Investors has paid dividends for 54 consecutive years and that the preferred stock yields 10.86%; InvestingPro subscribers have access to over eight additional tips on the company.

Eugene S Stark, who serves as Vice President Administration/Chief Compliance Officer/Principal Financial Officer at General American Investors Co Inc (NYSE: GAM), has increased his direct holding in the company’s 5.95% preferred stock.

The transaction consisted of an acquisition of 3,000 shares of the 5.95% Preferred Stock at a per-share price of $24.95, bringing the aggregate cost of the purchase to $74,850. As a result of this buy, Stark now directly holds 27,000 shares of the stated preferred issue.

The purchase comes while General American Investors is characterized by a long record of dividend payments. InvestingPro data cited by the company notes that the firm has distributed dividends for 54 consecutive years. The current dividend yield on the preferred shares is reported at 10.86%.

InvestingPro also indicates that subscribers gain access to additional analytical material on the company; specifically, InvestingPro subscribers are able to view more than eight extra tips related to GAM’s financial condition and performance metrics.


Details of the transaction

  • Shares purchased: 3,000 of 5.95% Preferred Stock
  • Price per share: $24.95
  • Total transaction value: $74,850
  • Post-transaction direct holding by Eugene S Stark: 27,000 shares

Dividend context

The company’s preferred stock carries a stated dividend rate of 5.95%. The published InvestingPro figures referenced in company materials also highlight a 54-year streak of dividend payments and a current yield of 10.86% on the preferred stock.


Summary and context for readers

The reported insider purchase increases an executive’s direct ownership in a high-yielding preferred issue while the company is presented as having a lengthy history of paying dividends. The article does not provide additional commentary from the company or the insider about the motivation behind the purchase, nor does it include further corporate disclosures beyond the share count and dividend figures cited above.

Risks

  • The report does not disclose the insider’s rationale for the purchase, leaving the motive and timing unexplained - this is an information gap affecting investor assessment.
  • The article does not provide forward-looking commentary or company statements regarding dividend policy or capital plans, so future dividend outcomes are not addressed within the available information.
  • Publicly available details in the article are limited to the transaction, dividend history, and yield; additional material that could influence valuation or investor decisions is not included.

More from Insider Trading

Marvell Technology President Sells $1.1M in Stock as Shares Trade Near Yearly High Apr 6, 2026 Edward Lampert Sells $58.5 Million in Lands’ End Stock; Company Posts Q4 Shortfall, Announces $100M Buyback Program Apr 6, 2026 NeonC/NeOnc President Buys $153,398 in Stock as Company Advances Financing and Clinical Timeline Apr 6, 2026 Edwards Lifesciences Executive Executes Option Exercise, Sells 1,019 Shares Apr 6, 2026 Penumbra Director Executes $32,822 Stock Sale Amid Deal and Upbeat Quarterly Results Apr 6, 2026